European Surgical Research
Original Paper
Argon Delays Initiation of Liver Regeneration after Partial Hepatectomy in RatsUlmer T.F.a · Fragoulis A.a · Dohmeier H.b · Kroh A.a · Andert A.a · Stoppe C.b · Alizai H.a · Klink C.a · Coburn M.b · Neumann U.P.aDepartments of aGeneral, Visceral, and Transplantation Surgery and bAnesthesiology, University Hospital of RWTH Aachen, Aachen, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: July 04, 2016
Accepted: February 28, 2017
Published online: April 22, 2017
Issue release date: December 2017
Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 2
ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)
For additional information: https://www.karger.com/ESR
Abstract
Background: The liver can heal up to restitutio ad integrum following damage resulting from various causes. Different studies have demonstrated the protective effect of argon on various cells and organs. To the best of our knowledge, the organ-protective effects of the noble gas argon on the liver have not yet been investigated, although argon appears to influence signal paths that are well-known mediators of liver regeneration. We hypothesized that argon inhalation prior to partial hepatectomy (70%) has a positive effect on the initiation of liver regeneration in rats. Methods: Partial hepatectomy (70%) with or without inhaled argon (50 vol%) was performed for 1 h. Liver tissue was harvested after 3, 36, and 96 h to analyze the mRNA and protein expression of hepatocyte growth factor (HGF), interleukin-6 (IL-6), tumor necrosis factor-α, and extracellular signal-regulated kinase 1/2. Histological tissue samples were prepared for immunohistochemistry (bromodeoxyuridine [BrdU], Ki-67, and TUNEL) and blood was analyzed regarding the effects of argon on liver function. Statistical analyses were performed using 1-way ANOVA followed by the post hoc Tukey-Kramer test. Results: After 3 h, the primary outcome parameter of hepatocyte proliferation was significantly reduced with argon 50 vol% inhalation in comparison to nitrogen inhalation (BrdU: 15.7 ± 9.7 vs. 7.7 ± 3.1 positive cells/1,000 hepatocytes, p = 0.013; Ki-67: 17.6 ± 13.3 vs. 4.7 ± 5.4 positive cells/1,000 hepatocytes, p = 0.006). This was most likely mediated by significant downregulation of HGF (after 3 h: 5.2 ± 3.2 vs. 2.3 ± 1.0 fold, p = 0.032; after 96 h: 2.1 ± 0.5 vs. 1.3 ± 0.3 fold, p = 0.029) and IL-6 (after 3 h: 43.7 ± 39.6 vs. 8.5 ± 9.2 fold, p = 0.032). Nevertheless, we could detect no significant effect on the weight of the residual liver, liver-body weight ratio, or liver blood test results after argon inhalation. Conclusion: Impairment of liver regeneration was apparent after argon 50 vol% inhalation that was most probably mediated by downregulation of HGF and IL-6 in the initial phase. However, the present study was not adequately powered to prove that argon has detrimental effects on the liver. Further studies are needed to evaluate the effects of argon on livers with preexisting conditions as well as on ischemia-reperfusion models.
© 2017 S. Karger AG, Basel
Related Articles:
References
- Agrawal S, Belghiti J: Oncologic resection for malignant tumors of the liver. Ann Surg 2011;253:656-665.
- Fausto N, Campbell JS, Riehle KJ: Liver regeneration. Hepatology 2006;43:S45-S53.
- Michalopoulos GK: Liver regeneration. J Cell Physiol 2007;213:286-300.
- Yarin YM, Amarjargal N, Fuchs J, Haupt H, Mazurek B, Mozorova SV, et al: Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear Res 2005;201:1-9.
- Ulbrich F, Schallner N, Coburn M, Loop T, Lagrèze WA, Biermann J, et al: Argon inhalation attenuates retinal apoptosis after ischemia/reperfusion injury in a time- and dose-dependent manner in rats. PLoS One 2014;9:e115984.
- David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH: Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One 2012;7:e30934.
- Zhuang L, Yang T, Zhao H, Fidalgo AR, Vizcaychipi MP, Sanders RD, et al: The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012;40:1724-1730.
- Höllig A, Schug A, Fahlenkamp AV, Rossaint R, Coburn M; Argon Organo-Protective Network (AON): Argon: systematic review on neuro- and organoprotective properties of an “inert” gas. Int J Mol Sci 2014;15:18175-18196.
- Alderliesten T, Favie LM, Neijzen RW, Auwärter V, Nijboer CH, Marges RE, et al: Neuroprotection by argon ventilation after perinatal asphyxia: a safety study in newborn piglets. PLoS One 2014;9:e113575.
- Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, et al: Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007;105:562-569.
- Rizvi M, Jawad N, Li Y, Vizcaychipi MP, Maze M, Ma D: Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood) 2010;235:886-891.
- Irani Y, Pype JL, Martin AR, Chong CF, Daniel L, Gaudart J, et al: Noble gas (argon and xenon)-saturated cold storage solutions reduce ischemia-reperfusion injury in a rat model of renal transplantation. Nephron Extra 2011;1:272-282.
- Fahlenkamp AV, Coburn M, de Prada A, Gereitzig N, Beyer C, Haase H, et al: Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats. Med Gas Res 2014;4:11.
- Frémin C, Ezan F, Boisselier P, Bessard A, Pagès G, Pouysségur J, et al: ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology 2007;45:1035-1045.
- Guerra MT, Fonseca EA, Melo FM, Andrade VA, Aguiar CJ, Andrade LM, et al: Mitochondrial calcium regulates rat liver regeneration through the modulation of apoptosis. Hepatology 2011;54:296-306.
- Ryang YM, Fahlenkamp AV, Rossaint R, Wesp D, Loetscher PD, Beyer C, et al: Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2011;39:1448-1453.
-
Higgins GM, Anderson RM: Experimental pathology of liver; restoration of liver of white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
- Wruck CJ, Götz ME, Herdegen T, Varoga D, Brandenburg LO, Pufe T: Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 2008;73:1785-1795.
- Ramakers C, Ruijter JM, Deprez RH, Moorman AF: Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003;339:62-66.
- Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
- Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH: Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 2003;38:674-682.
- Coburn M, Sanders RD, Ma D, Fries M, Rex S, Magalon G, et al: Argon: the “lazy” noble gas with organoprotective properties. Eur J Anaesthesiol 2012;29:549-551.
- Fahlenkamp AV, Rossaint R, Haase H, Al Kassam H, Ryang YM, Beyer C, et al: The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur J Pharmacol 2012;674:104-111.
- Ulbrich F, Kaufmann KB, Coburn M, Lagrèze WA, Roesslein M, Biermann J, et al: Neuroprotective effects of argon are mediated via an ERK-1/2 dependent regulation of heme-oxygenase-1 in retinal ganglion cells. J Neurochem 2015;134:717-727.
- Wilhelm S, Ma D, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002;96:1485-1491.
- Zhao H, Luo X, Zhou Z, Liu J, Tralau-Stewart C, George AJ, et al: Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats. Kidney Int 2014;85:112-123.
- David HN, Haelewyn B, Risso JJ, Abraini JH: Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator. Naunyn Schmiedebergs Arch Pharmacol 2013;386:91-95.
- Quillin ML, Breyer WA, Griswold IJ, Matthews BW: Size versus polarizability in protein-ligand interactions: binding of noble gases within engineered cavities in phage T4 lysozyme. J Mol Biol 2000;302:955-977.
- Haber BA, Mohn KL, Diamond RH, Taub R: Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993;91:1319-1326.
- Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60-66.
- Riehle KJ, Dan YY, Campbell JS, Fausto N: New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26(suppl 1):203-212.
- Iwai M, Cui TX, Kitamura H, Saito M, Shimazu T: Increased secretion of tumour necrosis factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy. Cytokine 2001;13:60-64.
- Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
- Li W, Liang X, Leu JI, Kovalovich K, Ciliberto G, Taub R: Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 2001;33:1377-1386.
- Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
- Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK: Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999;59:3954-3960.
- Zarnegar R, DeFrances MC, Kost DP, Lindroos P, Michalopoulos GK: Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991;177:559-565.
- Roselli HT, Su M, Washington K, Kerins DM, Vaughan DE, Russell WE: Liver regeneration is transiently impaired in urokinase-deficient mice. Am J Physiol 1998;275:G1472-G1479.
- Mars WM, Zarnegar R, Michalopoulos GK: Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993;143:949-958.
- Borowiak M, Garratt AN, Wüstefeld T, Strehle M, Trautwein C, Birchmeier C: Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 2004;101:10608-10613.
- Argast GM, Campbell JS, Brooling JT, Fausto N: Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J Biol Chem 2004;279:34530-34536.
- Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, et al: The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes. Mol Cell Biol 1999;19:6003-6011.
- Gao W, Zhou P, Ma X, Tschudy-Seney B, Chen J, Magner NL, et al: Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK signaling pathway in vitro. PLoS One 2014;9:e112698.
- Won M, Park KA, Byun HS, Kim YR, Choi BL, Hong JH, et al: Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration. J Hepatol 2009;51:67-76.
- Frémin C, Bessard A, Ezan F, Gailhouste L, Régeard M, Le Seyec J, et al: Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2. Hepatology 2009;49:930-939.
- Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A, et al: Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009;13:R206.
Article / Publication Details
Received: July 04, 2016
Accepted: February 28, 2017
Published online: April 22, 2017
Issue release date: December 2017
Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 2
ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)
For additional information: https://www.karger.com/ESR
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission